MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Bolt Biotherapeutics, Inc. Common Stock

BOLT

#3845
Bolt Biotherapeutics, Inc. Common Stock
4.52
-3.83%
Sector:
Base:
Profit Currency:
Daily Range
4.52
4.52
Year Range
0.26
7.35
Daily Change
-3.83%
Monthly Change
-35.52%
6 month change
-9.24%
Year Change
+861.70%
Previous Close
4.70
Open
4.52
Bid
Ask
Low
4.52
High
4.52
Volume
1
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. BOLT
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Zacks Zacks
BOLT FENC
2025.11.12
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates
Zacks Zacks
BOLT PTGX
2025.11.04
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Investing Investing
BOLT
2025.10.24
Bolt Biotherapeutics CEO Quinn buys shares worth $686
Investing Investing
BOLT
2025.10.24
Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686
Investing Investing
BOLT
2025.10.20
Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright
Benzinga Benzinga
FDUS BOLT EFX TRU LAC
2025.10.02
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)
Investing Investing
BOLT
2025.10.01
Bolt Biotherapeutics delays clinical data, cuts workforce by half
Investing Investing
BOLT
2025.10.01
Bolt Biotherapeutics stock falls after clinical data delay to 2026
Investing Investing
BOLT
2025.09.03
Bolt Biotherapeutics stock price target cut to $6 from $20 at Leerink Partners
Investing Investing
BOLT
2025.08.14
Bolt earnings missed by $4.15, revenue topped estimates
Zacks Zacks
BOLT
2025.08.14
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Zacks Zacks
ANIP BOLT
2025.08.08
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd